tiprankstipranks
Organon Reports 2024 Financial Results and 2025 Outlook
PremiumCompany AnnouncementsOrganon Reports 2024 Financial Results and 2025 Outlook
1M ago
Organon sees FY25 revenue $6.13B-$6.33B, consensus $6.43B
Premium
The Fly
Organon sees FY25 revenue $6.13B-$6.33B, consensus $6.43B
1M ago
Organon reports Q4 EPS 90c, consensus 87c
Premium
The Fly
Organon reports Q4 EPS 90c, consensus 87c
1M ago
FDA approves Organon’s VTAMA cream, 1% for the treatment for AD
PremiumThe FlyFDA approves Organon’s VTAMA cream, 1% for the treatment for AD
3M ago
Organon price target lowered to $15 from $17 at BofA
Premium
The Fly
Organon price target lowered to $15 from $17 at BofA
3M ago
Organon reports FDA extension of target action date of review of Vtama sNDA
Premium
The Fly
Organon reports FDA extension of target action date of review of Vtama sNDA
5M ago
Organon reports Q3 EPS 87c, consensus 90c
PremiumThe FlyOrganon reports Q3 EPS 87c, consensus 90c
5M ago
Organon, Shanghai Henlius Biotech: FDA accepts BLA for HLX14
Premium
The Fly
Organon, Shanghai Henlius Biotech: FDA accepts BLA for HLX14
5M ago
Organon completes acquisition of Dermavant
Premium
The Fly
Organon completes acquisition of Dermavant
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100